Angola, a country in Southern Africa, has been facing an increasing burden of diabetes. As a result, the demand for anti-diabetes drugs has been on the rise in the country.
Customer preferences: Patients in Angola prefer to use oral anti-diabetes drugs over insulin injections. This is mainly due to the convenience of oral medication and the fear of needles. Additionally, affordability is also a major consideration for customers in Angola.
Trends in the market: The anti-diabetes drugs market in Angola has been witnessing a shift towards generic drugs. This is mainly due to the high cost of branded drugs, which are not affordable for a majority of the population. The availability of generic drugs has made it easier for patients to access medication at a lower cost.
Local special circumstances: One of the major challenges in the anti-diabetes drugs market in Angola is the lack of healthcare infrastructure. This has led to a shortage of healthcare professionals and limited access to medication in remote areas. Additionally, the prevalence of counterfeit drugs in the market is also a major concern.
Underlying macroeconomic factors: The Angolan economy heavily relies on oil exports, which has been facing a decline in recent years. This has led to a shortage of foreign currency, making it difficult for the government to import medication. Additionally, the country has been facing political instability, which has further impacted the healthcare sector.In conclusion, the anti-diabetes drugs market in Angola is witnessing a shift towards generic drugs due to affordability and convenience. However, the lack of healthcare infrastructure and prevalence of counterfeit drugs remain a major challenge. The underlying macroeconomic factors such as the decline in oil exports and political instability are also impacting the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
